In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality compared with those not taking the drugs. The mortality benefit was statistically ...
Add Yahoo as a preferred source to see more of our stories on Google. Rates of colon cancer in people under 50 have grown in recent decades. One study found that 82% of young colon cancer patients ...
Immunotherapy in patients with early-stage microsatellite instable (MSI-H)/mismatch repair deficient (dMMR) colorectal cancer (CRC) treated in a community setting. Table showing complications in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results